| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $15.5M | +517.5% |
| R&D Expense | $56.8M | -37.7% |
| SG&A Expense | $30.0M | -19.6% |
| Operating Income | -$72.4M | +55.4% |
| Interest Expense | $5.0M | +31.6% |
| Income Tax | $0 | — |
| Net Income | -$111.6M | +32.8% |
| EPS (Basic) | -$0.96 | +74.6% |
| EPS (Diluted) | -$0.96 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $143.9M | +63.8% |
| Current Assets | $149.9M | +55.4% |
| Total Assets | $172.7M | +36.8% |
| Current Liabilities | $36.8M | -41.5% |
| Long-term Debt | $40.5M | +6.7% |
| Total Liabilities | $97.8M | -22.0% |
| Stockholders' Equity | $74.9M | +7796.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$73.0M | +17.4% |
| Capital Expenditures | $3.9M | -81.2% |
| Investing Cash Flow | -$7.4M | +70.5% |
| Financing Cash Flow | $136.4M | +161.8% |
| Free Cash Flow | -$76.9M | +29.5% |
| +74.6% |